ORAMED PHARMACEUTICALS INC. (ORMP) Total liabilities 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) total liabilities at each fiscal year-end, per SEC filings.
$31.1MFY2025 · since FY2016: $16.6M → $31.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $31.1M | — |
| FY2023 | $56.7M | +477.1% |
| FY2022 | $9.8M | -19.6% |
| FY2021 | $12.2M | +4.0% |
| FY2020 | $11.8M | -23.0% |
| FY2019 | $15.3M | -6.2% |
| FY2018 | $16.3M | -16.4% |
| FY2017 | $19.5M | +17.0% |
| FY2016 | $16.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ORMP financial trends
ORMP RevenueORMP Net incomeORMP Net marginORMP Gross profitORMP Gross marginORMP Operating incomeORMP Operating marginORMP Operating cash flowORMP Free cash flowORMP Capital expendituresORMP Return on equityORMP Stock buybacksORMP Dividends paidORMP Total assetsORMP Shareholders’ equityORMP overview →